START Launches Hope Hub for Community Cancer Trial Access

The new platform is designed to break down barriers to early-phase trial access, bringing “Hope Through Access” to communities and patients who need it most.

The START Center for Cancer Research , the world’s largest early-phase community-based cancer trial site network, announced the launch of the START Hope Hub, a powerful new digital patient and physician-focused platform that connects patients, caregivers, advocacy groups, and referring oncologists with quick access to START’s 720+ oncology clinical trials and informational resources.

Health Technology Insights: Altera Digital Health Makes Sunrise 25.1 Generally Available to Hospitals and Health Systems

With more than 80% of cancer patients treated in community settings, and most early-phase trials still concentrated in major academic centers, access to emerging therapies remains out of reach for most patients. The START Hope Hub was built to change that.

“The START Hope Hub is a major leap forward in how we bring cancer clinical trials, oncology trial resources, and empathetic navigators to patients and their treating oncologists,” said Nick Slack, MBE, Chairman and CEO of START. “For nearly 20 years, START has been focused on delivering our mission of “hope through access” by bringing cutting-edge clinical trial options to patients and their physicians where care is delivered. Since day one, we have believed that comprehensive cancer care, which includes trials, should be available to all patients and physicians – not just those in Academic Medical Centers. ‘Access’ to trials transcends the trial itself. It requires critical information about trial options, helpful and easy-to-navigate resources, and patient-focused professionals who can help patients, or their physicians, identify an appropriate path to gain access to a trial when needed. Underpinning this important initiative is a focus on human-to-human interaction. The Hope Hub is the next step in START’s evolution, ensuring that access to trials is not limited by geography.”

Built with both technology and compassion at its core, the START Hope Hub combines intelligent trial-matching tools with personalized human support—helping patients and referring oncologists navigate clinical trial options faster and with greater confidence. Users can search by location, distance from home, disease type, medical condition, study identifiers, and more. With over 720 active trials spanning every major tumor type and biomarker, the START Hope Hub offers a single, unified gateway to START’s global research network.

Health Technology Insights: New Report Exposes Confidence Crisis in Healthcare IT Security

“As a physician, I know how daunting it can be for families to explore clinical trials,” said Dr. Chris Takimoto, Global Chief Medical Officer at START. “What the START Hope Hub provides is clarity, connection, and most importantly—possibility. It empowers oncologists and caregivers alike to explore the right options at the right time for the patients who need them most.”

The START Hope Hub also serves as a critical resource for patient advocacy organizations seeking to share real-time trial information with their communities. By helping the right patients reach the right trials earlier, the START Hope Hub has the potential to improve lives—and outcomes—faster. With START’s dedicated Hope Team available to support every referral and inquiry, patients and physicians never navigate the process alone.

The START Hope Hub also delivers strategic value to biopharmaceutical sponsors by strengthening START’s unmatched ability to enroll trials successfully so that promising new therapies reach patients who need these valuable options – and that the drug development process moves forward so that promising therapies can reach more patients faster. As the platform continues to grow alongside START’s expanding site network, the START Hope Hub will be a critical feature enabling drug developers to reach more patients for their trials. This means early-phase trials can open, accrue, and complete more quickly, thereby reducing cycle times, de-risking development plans, and helping drug developers advance their most promising assets.

Health Technology Insights: HRT Club, Posterity Health Partner for Inclusive Hormone Care

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – PR Newswire

Tags: Advocacy Groups, Community-Based Cancer Trials, Connect Patients, healthcare, physicians, START

HealthTech Media Room

HealthTech Media Room is a leading B2B media publication platform providing in-depth coverage of the rapidly evolving healthcare technology and academic research sectors. Specializing in key focus areas such as MedTech, Pharma, Digital Health, Health IT, and Biotech, HealthTech Media Room delivers the latest news, trends, and insights across the entire HealthTech landscape. From breakthrough medical devices and innovative pharmaceuticals to cutting-edge digital health solutions, the platform highlights key players, strategic partnerships, and transformative technologies shaping the future of healthcare. Serving as a trusted resource for industry professionals, thought leaders, and healthcare organizations, HealthTech Media Room is dedicated to driving conversations and knowledge sharing in the global HealthTech community.